Qian Xu, M.D. Ph.D.

Qian Xu, M.D. Ph.D. has worked in the pharmaceutical industry since 2008. Starting as a Research Fellow at the University of California, Davis, they then moved to Roche Pharmaceuticals in 2011 as an Assistant Medical Director. In 2013, they joined Eli Lilly and Company as a Clinical Research Physician, followed by a role as an Associate Director Clinical Research at Novartis in 2016. From 2017 to 2021, they worked at Jiangsu Hengrui Medicine Co., Ltd. in two roles, first as a Senior Medical Director and Immunology Group Head and then as a Medical Director and Immunology Group Head. Currently, they are a Vice President of Clinical Development at Inmagene Biopharmaceuticals.

Qian Xu, M.D. Ph.D. completed advanced training in clinical research at the University of California, San Francisco in 2013. Prior to that, they earned a Doctor of Philosophy (Ph.D.) in Medicine from the National University of Singapore.